Global Cervical Cancer Diagnostic Market Overview:
IMARC Group latest report titled” Cervical Cancer Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on the cervical cancer diagnostics market report.
The report also includes competitor and regional analysis, and contemporary advancements in the market. The global cervical cancer diagnostics market reached US$ 7.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.9 Billion by 2027, exhibiting a growth rate (CAGR) of 5.57% during 2022-2027.
Cervical cancer refers to a type of cancer that occurs in the cervix, the lower part of the uterus. There are two main types of cervical cancer, namely adenocarcinoma and squamous cell carcinoma. Cervical cancer diagnosis is performed through various advanced laboratory tests, tools and procedures to evaluate abnormal cells and strains of human papillomavirus (HPV).
These tests and procedures include conization, punch biopsy, endocervical curettage and the electrical wire loop for a thorough examination of the cervix during colposcopy. These procedures are followed by blood tests, body computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scans to determine the progress of the disease.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Get a sample copy of this Report: https://www.imarcgroup.com/cervical-cancer-diagnostics-market/requestsample
Global Cervical Cancer Diagnostic Market Trends:
Other than this, the growing adoption of advanced diagnostic procedures for the early detection of cervical cancer, along with various awareness campaigns organized by government and non-government entities, is also contributing to the market growth.
In line with this, there is a growing consciousness regarding the availability of effective treatment and diagnosis methods, which is further contributing to the market growth. Leading players are developing home-based HPV testing kits to offer convenience to consumers, which is acting as another major growth-inducing factor.
Additionally, the escalating demand for minimally invasive screening procedures is supporting the market growth. Moreover, the growing emphasis on developing low-cost and efficient testing products is creating a positive outlook for the market.
Competitive Landscape with Key players:
- Abbott Laboratories
- Arbor Vita Corporation
- Becton
- Dickinson and Company
- Cooper Surgical Inc.
- Hoffmann-La Roche AG
- Guided Therapeutics Inc.
- Hologic Inc.
- Qiagen
- Quest Diagnostics Incorporated
- Siemens Healthcare GmbH
By Test Type:
- Pap Testing
- HPV Testing
- Cervical Biopsies
- Colposcopy
- Others
Breakup by Age Group:
- 20 to 35 years
- Above 35 years
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
